PFE vs XLO · P/E 20, rev $15.03B vs rev $31.3M
Pfizer Inc (PFE) versus Xilio Development Inc (XLO) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported XLO revenue for 2026-06-30 was $31.3M. Net income was -$15.9M. XLO currently screens at market cap $55.3M.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. XLO currently screens at market cap $55.3M.
Not investment advice. Open the PFE and XLO stock pages for the full models.
Not investment advice.